Literature DB >> 17404118

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

Thomas Frodl1, Cornelius Schüle, Gisela Schmitt, Christine Born, Thomas Baghai, Peter Zill, Ronald Bottlender, Rainer Rupprecht, Brigitta Bondy, Maximilian Reiser, Hans-Jürgen Möller, Eva M Meisenzahl.   

Abstract

CONTEXT: Brain-derived neurotrophic factor (BDNF) modulates hippocampal plasticity, which is believed to be altered in patients with major depression.
OBJECTIVE: To examine the effect of the BDNF Val66Met polymorphism on hippocampal and amygdala volumes in patients with major depression and in healthy control subjects.
DESIGN: Cross-sectional comparison between patients and controls.
SETTING: Inpatients with major depression from the Department of Psychiatry and Psychotherapy and healthy controls from the community were recruited. PARTICIPANTS: The study population of 120 subjects included 60 patients with major depression and 60 healthy controls. MAIN OUTCOME MEASURES: Using a combined strategy, hippocampal and amygdala volumes were estimated on high-resolution magnetic resonance images, and genotyping was performed for the BDNF Val66Met polymorphism.
RESULTS: Patients had significantly smaller hippocampal volumes compared with controls (P = .02). Significantly smaller hippocampal volumes were observed for patients and for controls carrying the Met-BDNF allele compared with subjects homozygous for the Val-BDNF allele (P = .006). With respect to amygdala volumes, no significant differences between patients and controls and no significant main effects for the BDNF Val66Met polymorphism were observed.
CONCLUSIONS: These genotype-related alterations suggest that Met-BDNF allele carriers might be at risk to develop smaller hippocampal volumes and may be susceptible to major depression. This study supports findings from animal studies that the hippocampus is involved in brain development and plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404118     DOI: 10.1001/archpsyc.64.4.410

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  135 in total

1.  Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.

Authors:  Rong-Jian Liu; Francis S Lee; Xiao-Yuan Li; Francis Bambico; Ronald S Duman; George K Aghajanian
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

2.  Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram.

Authors:  Naseema Cassimjee; Jean-Pierre Fouche; Michael Burnett; Christine Lochner; James Warwick; Patrick Dupont; Dan J Stein; Karen J Cloete; Paul D Carey
Journal:  Metab Brain Dis       Date:  2010-11-10       Impact factor: 3.584

3.  A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques.

Authors:  Francesca Cirulli; Andreas Reif; Sabine Herterich; K Peter Lesch; Alessandra Berry; Nadia Francia; Luigi Aloe; Christina S Barr; Stephen J Suomi; Enrico Alleva
Journal:  Psychoneuroendocrinology       Date:  2010-12-09       Impact factor: 4.905

4.  Effects of early-life adversity on white matter diffusivity changes in patients at risk for major depression.

Authors:  Thomas Frodl; Angela Carballedo; Andrew J Fagan; Danuta Lisiecka; Yolande Ferguson; James F Meaney
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

5.  Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus.

Authors:  Aysun Coskunoglu; Seda Orenay-Boyacioglu; Artuner Deveci; Mustafa Bayam; Ece Onur; Arzu Onan; Fethi S Cam
Journal:  Noise Health       Date:  2017 May-Jun       Impact factor: 0.867

Review 6.  Neurobiology of cognitive aging: insights from imaging genetics.

Authors:  Venkata S Mattay; Terry E Goldberg; Fabio Sambataro; Daniel R Weinberger
Journal:  Biol Psychol       Date:  2008-04-11       Impact factor: 3.251

7.  Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence.

Authors:  Marcin Wojnar; Kirk J Brower; Stephen Strobbe; Mark Ilgen; Halina Matsumoto; Izabela Nowosad; Elzbieta Sliwerska; Margit Burmeister
Journal:  Alcohol Clin Exp Res       Date:  2009-01-27       Impact factor: 3.455

8.  Multimodal imaging of a tescalcin (TESC)-regulating polymorphism (rs7294919)-specific effects on hippocampal gray matter structure.

Authors:  U Dannlowski; H J Grabe; K Wittfeld; J Klaus; C Konrad; D Grotegerd; R Redlich; T Suslow; N Opel; P Ohrmann; J Bauer; P Zwanzger; I Laeger; C Hohoff; V Arolt; W Heindel; M Deppe; K Domschke; K Hegenscheid; H Völzke; D Stacey; H Meyer Zu Schwabedissen; H Kugel; B T Baune
Journal:  Mol Psychiatry       Date:  2014-04-29       Impact factor: 15.992

9.  Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

Review 10.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.